1. Home
  2. CGTX vs GGT Comparison

CGTX vs GGT Comparison

Compare CGTX & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • GGT
  • Stock Information
  • Founded
  • CGTX 2007
  • GGT 1994
  • Country
  • CGTX United States
  • GGT United States
  • Employees
  • CGTX N/A
  • GGT N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • GGT Trusts Except Educational Religious and Charitable
  • Sector
  • CGTX Health Care
  • GGT Finance
  • Exchange
  • CGTX Nasdaq
  • GGT Nasdaq
  • Market Cap
  • CGTX 158.8M
  • GGT 152.3M
  • IPO Year
  • CGTX 2021
  • GGT N/A
  • Fundamental
  • Price
  • CGTX $1.74
  • GGT $4.00
  • Analyst Decision
  • CGTX Strong Buy
  • GGT
  • Analyst Count
  • CGTX 3
  • GGT 0
  • Target Price
  • CGTX $2.83
  • GGT N/A
  • AVG Volume (30 Days)
  • CGTX 2.1M
  • GGT 59.7K
  • Earning Date
  • CGTX 11-12-2025
  • GGT 01-01-0001
  • Dividend Yield
  • CGTX N/A
  • GGT 15.56%
  • EPS Growth
  • CGTX N/A
  • GGT N/A
  • EPS
  • CGTX N/A
  • GGT 0.83
  • Revenue
  • CGTX N/A
  • GGT N/A
  • Revenue This Year
  • CGTX N/A
  • GGT N/A
  • Revenue Next Year
  • CGTX N/A
  • GGT N/A
  • P/E Ratio
  • CGTX N/A
  • GGT $6.90
  • Revenue Growth
  • CGTX N/A
  • GGT N/A
  • 52 Week Low
  • CGTX $0.22
  • GGT $4.32
  • 52 Week High
  • CGTX $3.83
  • GGT $7.00
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 51.92
  • GGT 32.87
  • Support Level
  • CGTX $1.67
  • GGT $4.22
  • Resistance Level
  • CGTX $2.00
  • GGT $4.17
  • Average True Range (ATR)
  • CGTX 0.16
  • GGT 0.07
  • MACD
  • CGTX 0.02
  • GGT -0.02
  • Stochastic Oscillator
  • CGTX 59.48
  • GGT 1.42

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

Share on Social Networks: